Global Neurostimulation Devices Market Forecast to 2022 - Leading Players are Abbott, Boston Scientific, LivaNova, Medtronic, and Nevro - ResearchAndMarkets.com

The "Global Neurostimulation Devices Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The neurostimulation devices market will register a CAGR of almost 11% by 2022.

The prevalence of several neurological disorder is increasing across the world

The probability of diseases such as AD, PD, UI, fecal incontinence, epilepsy, dementia, and movement disorders increases significantly with age. Hence the prevalence of neurological disorders increases due to the growth of the aging population.

Other risk factors associated with neurological disorders such as high blood pressures (BP), obesity and the consumption of alcohol and tobacco are also increasing. Therefore, the rising prevalence of neurological disorders drives the growth of the market.

Rising prevalence of neurological disorders

The increasing prevalence of several neurological disorders is increasingly, globally. Therefore, the aging population will positively affect the prevalence of neurological disorders.

High cost of neurostimulation devices and procedures

The high cost of neurostimulation devices limits their adoption in several developing countries. The availability of information about the cost of neurostimulation devices is limited. Therefore, gathering data about the high cost of neurostimulation devices is s complex task.

Key Players

• Abbott
• Boston Scientific
• LivaNova
• Medtronic
• Nevro

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: MARKET SIZING

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

• Overview
• Comparison by product
• Implantable neurostimulation devices
• External neurostimulation devices
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

• Expanding indications of neurostimulation devices
• Increasing number of initiatives that support research related to neurostimulation technology

PART 13: VENDOR LANDSCAPE

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Boston Scientific
• LivaNova
• Medtronic
• Nevro

For more information about this report visit https://www.researchandmarkets.com/research/d7wtsq/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190116005646/en/